Nitric oxide synthase gene polymorphisms and prostate cancer risk

Carcinogenesis

Volumn 30, Issue 4, 2009, Pages 621-625

  Lee, Kyoung Mu ^a   Kang, Daehee ^b   Park, Sue Kyung ^b   Berndt, Sonja I ^a   Reding, Douglas ^c   Chatterjee, Nilanjan ^a   Chanock, Stephen ^a   Huang, Wen Yi ^a   Hayes, Richard B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Seoul National University College of Medicine   (South Korea)

^c MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; LYCOPENE; NITRIC OXIDE SYNTHASE 2A; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CLASSIFICATION; CANCER RISK; CARCINOGENESIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ANTIOXIDANTS; BETA CAROTENE; CAROTENOIDS; CASE-CONTROL STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RISK FACTORS; VITAMIN E;

EID: 64349097804     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp028     Document Type: Article

References (25)

1. Parnes,H.L. et al. (2005) Prevention of hormone-related cancers: prostate Cancer. J. Clin. Oncol., 23, 368-377.
2. Yeager,M. et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet., 39 645-649.
3. Zheng,S.L. et al. (2007) Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J. Natl Cancer Inst., 99, 1525-1533.
4. Duggan,D. et al. (2007) Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DA-B2IP. J. Natl Cancer Inst., 99, 1836-1844.
5. Thomas,G. et al. (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet., 40, 310-315.
6. Wink,D.A. et al. (1998) The multifaceted roles of nitric oxide in cancer. Carcinogenesis, 19, 711-721.
7. Lancaster,J.R.Jr et al. (2006) Tumors face NO problems? Cancer Res., 66, 6459-6462.
8. Klotz,T. et al. (1998) Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer, 82, 1897-1903.
9. Uotila,P. et al. (2001) Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer. Urol. Res., 29, 23-28.
10. Tong,X. et al. (2004) eNOS protects prostate cancer cells from TRAIL-induced apoptosis. Cancer Lett., 210, 63-71.
11. Medeiros,R. et al. (2002) Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer. Eur. J. Cancer Prev., 11, 343-350.
12. Kang,D. et al. (2007) Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study. Cancer Epidemiol. Biomarkers Prev., 16, 1581-1586.
13. Tippett,K.S. et al. (1997) Design and operation: The continuing survey of food intakes by individuals and the diet and health knowledge survey, 1994-96. In Continuing Survey of Food Intakes by Individuals 1994-96, Nationwide Food Surveys Rep. No. 96-1. US Department of Agriculture, Agricultural Research Service.
14. Packer,B.R. et al. (2006) SNP500Cancer: A public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res., 34 D617-D621.
15. Veldman,B.A. et al. (2002) The Glu298Asp-polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J. Hypertens., 20, 2023-2027.
16. Hefler,L.A. et al. (2002) Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancer. Gynecol. Oncol., 86, 134-137.
17. Schaid,D.J. et al. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet., 70, 425-434.
18. Medeiros,R. et al. (2003) Endothelial nitric oxide synthase gene polymorphisms and the shedding of circulating tumour cells in the blood of prostate cancer patients. Cancer Lett., 189, 85-90.
19. Lala,P.K. et al. (1998) Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metastasis Rev., 81 889-896.
20. Ng,Q.S. et al. (2007) Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: A phase I study. Lancet Oncol. 8, 111-118.
21. Cronauer,M.V. et al. (2007) Nitric oxide-mediated inhibition of androgen receptor activity: Possible implications for prostate cancer progression. Oncogene, 26, 1875-1884.
22. Lee,K.M. et al. (2007) Genetic polymorphisms of NOS3 are associated with the risk of invasive breast cancer with lymph node involvement. Breast Cancer Res. Treat., 106, 433-438.
23. Wink,D.A. et al. (2001) Mechanisms of the antioxidant effects of nitric oxide. Antioxid. Redox Signal, 3, 203-213.
24. Wartenberg,M. et al. (2003) Reactive oxygen species-mediated regulation of eNOS and iNOS expression in multicellular prostate tumor spheroids. Int. J. Cancer, 104, 274-282.
25. Lim,H.W. et al. (2005) Up-regulation of defense enzymes is responsible for low reactive oxygen species in malignant prostate cancer cells. Exp. Mol. Med., 37, 497-506.